Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|December 10, 1999
In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniaeP M Roblin, M R HammerschlagInternational Journal of Antimicrobial Agents|February 24, 2001
In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatisP M Roblin, M R HammerschlagInternational Journal of Antimicrobial Agents|June 16, 2000
Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniaeM R Hammerschlag, P M RoblinAntimicrobial Agents and Chemotherapy|April 29, 1998
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniaeP M Roblin, M R HammerschlagAntimicrobial Agents and Chemotherapy|June 13, 1998
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniaeP M Roblin, M R HammerschlagAntimicrobial Agents and Chemotherapy|February 4, 1998
Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumoniaP M Roblin, M R HammerschlagThe Journal of Infectious Diseases|March 14, 1998
Antibody response to Chlamydia pneumoniae infection in children with respiratory illnessA Kutlin, P M Roblin, M R HammerschlagAntimicrobial Agents and Chemotherapy|September 3, 1999
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection modelA Kutlin, P M Roblin, M R HammerschlagAntimicrobial Agents and Chemotherapy|June 1, 1994
In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniaeP M Roblin, G Montalban, M R HammerschlagAntimicrobial Agents and Chemotherapy|July 1, 1994
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumoniaP M Roblin, G Montalban, M R HammerschlagPageof 5